Chief Business Officer, Helsinn Group PhD in Molecular and Developmental Biology Georg Buchner is the group chief business officer of Helsinn group, a Swiss fully integrated, global biopharma company with a diversified pipeline of innovative oncology targeted therapies. Georg has over 20 years of experience in business, corporate development and consulting positions. His experience encompasses… Continue reading Georg Buchner
Chairman & CEO of Noventia Pharma Executive Chairman and a Shareholder of Pint Pharma Group CEO of Ferrer Italia Chairman & CEO of Noventia Pharma. He founded Noventia Pharma, a dynamic privately owned European Specialty Pharma Company with its H.Q. in Italy. Dr. Radaelli is also Executive Chairman and a Shareholder of Pint Pharma Group,… Continue reading Massimo Radaelli
Director of Business Development, Dynavax Technologies Phd Molecular Geneticist Lorenzo Tolleri is the Business Development Senior Director at Dynavax Technologies, where he deals with negotiation, execution, and alliance management of a broad range of transactions (both R&D and commercial). Before joining Dynavax Lorenzo was Director Business Development at GSK, where he was previously Patent Associate… Continue reading Lorenzo Tolleri
COO NLS Pharmaceutics ADYA Founder & Managing Director With about 25 years’ experience, Silvia combines corporate finance experience with a deep knowledge of drug development in private and public companies. Founder of ADYA, focused on strategic counseling and capital raising at global level, she she has been appointed as Chief Operating Officer at NLS Pharmaceutics,… Continue reading Silvia Panigone
DPhil in Biochemistry at the University of Oxford Member of UK Medical Research Council’s Technology Transfer Group Samantha Williams completed a DPhil in Biochemistry at the University of Oxford and then worked as a research scientist Unilever Research in the UK. She joined the UK Medical Research Council’s Technology Transfer Group in 1998 and has… Continue reading Samantha Williams
Co-Founder and Chief Executive Officer of Agribiomed Global Henk is the Co-Founder and Chief Executive Officer of Agribiomed Global, a cultivation, formulation and distribution company, with specialisation in Medical Cannabis, hemp CBD and relates industries. He has expert knowledge in Business Development, Commercial Operations, Strategic Management, International Regulatory Affairs, Pharmaceutical Law, GMP, accreditation and licensing… Continue reading Henk Krebs
CEO, founder of Mad K IP Consulting Director, Technology Transfer at Innovus, Stellenbosch University Co-editor of the publication “International Pharmaceutical Law” Madelein has over 27 years international experience as intellectual property practitioner, patent attorney and in-house counsel in the petrochemical and agri industries. She is the CEO and founder of Mad K IP Consulting (Pty)… Continue reading Madelein Kleyn
Patent attorney specialising in biotechnology and life sciences Partner and co-chair of the life sciences department at Spoor & Fisher, South Africa Secretary of the board of LES South Africa Chyreene is a South African patent attorney specialising in biotechnology and life sciences patent matters. She holds an MSc in genetics and has worked in… Continue reading Chyreene Truluck
GSK (invited) Rino Rappuoli is Head of Vaccine research and development (R&D) at GlaxoSmithKline (GSK) Vaccines. Previously, he has served as visiting scientist at Rockefeller University and Harvard Medical School and held roles at Sclavo, Vaccine Research and CSO, Chiron Corporation, and Novartis Vaccines.He is known globally for his work in vaccines and immunology. He… Continue reading Prof. Dr. Rino Rappuoli
